Clinical Trial Update: Observation of Inhalation of CXMCI-01 Essential Oil on Patients With Mild Cognitive Impairment [NA]

View source ↗

Summary

This clinical trial is evaluating inhalation of CXMCI-01 essential oil in patients with mild cognitive impairment. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• CXMCI-01 essential oil

Snippet

Sponsor: China Medical University Hospital | Conditions: Mild Cognitive Impairment | NA | Status: RECRUITING